Skip to main content
NCBI home page
Molecular Therapy Oncolytics logoLink to Molecular Therapy Oncolytics
. 2023 Aug 20;30:150. doi: 10.1016/j.omto.2023.08.002

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Chiara F Magnani ∗, Renier Myburgh, Silvan Brunn, Morgane Chambovey, Marianna Ponzo, Laura Volta, Francesco Manfredi, Christian Pellegrino, Steve Pascolo, Csaba Miskey, Nicolás Sandoval-Villegas, Zoltán Ivics, Judith A Shizuru, Dario Neri, Markus G Manz
PMCID: PMC10465849  PMID: 37654971

Main text

(Molecular Therapy: Oncolytics 30, 56–71; September 2023)

In the originally published version of this article, Nicolás Sandoval-Villegas was not present in the author list. He completed the western blot analysis for this study and should have been mentioned as an author.

The authors apologize for this error, and this has been corrected online.

Articles from Molecular Therapy Oncolytics are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES